Business Wire·Nov 12, 2025, 4:15 PM ET

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock granted inducement equity awards totaling 30,000 shares of common stock to one newly hired employee.
The awards consist of 17,143 inducement stock options & 12,857 inducement restricted stock units.
The inducement stock options carry an exercise price of $29.37, matching the closing stock price on November 10, 2025.
Stock option vesting begins at 25% on the first anniversary of the start date, with the remaining 75% vesting in 12 equal quarterly installments.
Restricted stock unit vesting occurs in four equal annual installments.
All vesting is contingent on the employee's continued service through the applicable vesting dates.
The grants were made under the Company's 2022 Inducement Equity Plan to comply with Nasdaq Listing Rule 5635(c)(4).
Scholar Rock is a late-stage biopharmaceutical company developing apitegromab for spinal muscular atrophy & other neuromuscular diseases.